Nancy Simonian
2015
In 2015, Nancy Simonian earned a total compensation of $1.1M as President & Chief Executive Officer at Syros Pharmaceuticals.
Compensation breakdown
| Option Awards | $723,248 |
|---|---|
| Salary | $425,000 |
| Other | $270 |
| Total | $1,148,518 |
Simonian received $723.2K in option awards, accounting for 63% of the total pay in 2015.
Simonian also received $425K in salary and $270 in other compensation.
Rankings
In 2015, Nancy Simonian's compensation ranked 7,274th out of 13,638 executives tracked by ExecPay. In other words, Simonian earned more than 46.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,274 out of 13,638 | 47th |
Division Manufacturing | 2,735 out of 5,187 | 47th |
Major group Chemicals And Allied Products | 983 out of 1,857 | 47th |
Industry group Drugs | 789 out of 1,531 | 49th |
Industry Pharmaceutical Preparations | 615 out of 1,179 | 48th |
Source: SEC filing on April 25, 2017.
Simonian's colleagues
We found two more compensation records of executives who worked with Nancy Simonian at Syros Pharmaceuticals in 2015.
News
Syros Pharmaceuticals CEO Nancy Simonian's 2023 pay falls 59% to $1.4M
April 23, 2024
Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
April 21, 2023
Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
April 21, 2022
Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
April 29, 2021
Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
April 28, 2020
Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
April 25, 2019